Secondhand Tobacco Smoke Exposure and Lung Adenocarcinoma In Situ/Minimally Invasive Adenocarcinoma (AIS/MIA)

The aim of this study was to estimate the effect of exposure to secondhand tobacco smoke on the incidence of lung adenocarcinoma in situ/minimally invasive adenocarcinoma (AIS/MIA). Data from seven case–control studies participating in the International Lung Cancer Consortium (ILCCO) were pooled, resulting in 625 cases of AIS/MIA and 7,403 controls, of whom 170 cases and 3,035 controls were never smokers. Unconditional logistic regression was used to estimate adjusted ORs (ORadj) and 95% confidence intervals (CI), controlling for age, sex, race, smoking status (ever/never), and pack-years of smoking. Study center was included in the models as a random-effects intercept term. Ever versus never exposure to secondhand tobacco smoke was positively associated with AIS/MIA incidence in all subjects (ORadj = 1.48; 95% CI, 1.14–1.93) and in never smokers (ORadj = 1.45; 95% CI, 1.00–2.12). There was, however, appreciable heterogeneity of ORadj across studies (P = 0.01), and the pooled estimates were largely influenced by one large study (40% of all cases and 30% of all controls). These findings provide weak evidence for an effect of secondhand tobacco smoke exposure on AIS/MIA incidence. Further studies are needed to assess the impact of secondhand tobacco smoke exposure using the newly recommended classification of subtypes of lung adenocarcinoma. Cancer Epidemiol Biomarkers Prev; 24(12); 1902–6. ©2015 AACR.

[1]  H. Morgenstern,et al.  Exposure to secondhand tobacco smoke and lung cancer by histological type: A pooled analysis of the International Lung Cancer Consortium (ILCCO) , 2014, International journal of cancer.

[2]  Sander Greenland,et al.  Maximum likelihood, profile likelihood, and penalized likelihood: a primer. , 2014, American journal of epidemiology.

[3]  Sander Greenland,et al.  Bayesian regression in SAS software. , 2013, International journal of epidemiology.

[4]  P. Bracci,et al.  Cigarette Smoking Associated With Lung Adenocarcinoma In Situ in a Large Case-Control Study (SFBALCS) , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[5]  Masahiro Tsuboi,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  H. Morgenstern,et al.  Tobacco smoking as a risk factor of bronchioloalveolar carcinoma of the lung: pooled analysis of seven case–control studies in the International Lung Cancer Consortium (ILCCO) , 2010, Cancer Causes & Control.

[7]  Ugolini Donatella,et al.  The CREST Biorepository: A Tool for Molecular Epidemiology and Translational Studies on Malignant Mesothelioma, Lung Cancer, and Other Respiratory Tract Diseases , 2008, Cancer Epidemiology Biomarkers & Prevention.

[8]  W. Bamlet,et al.  Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. , 2008, Archives of internal medicine.

[9]  A. Schwartz,et al.  Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  D. Arenberg Bronchioloalveolar lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). , 2007, Chest.

[11]  R. Rosell,et al.  Bronchioloalveolar carcinoma: a review. , 2006, Clinical lung cancer.

[12]  H. Morgenstern,et al.  Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus , 2006, International journal of cancer.

[13]  S. Land,et al.  GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study. , 2004, Carcinogenesis.

[14]  R. Govindan,et al.  The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database. , 2004, Lung cancer.

[15]  T. Sellers,et al.  Environmental tobacco smoke exposure in women with lung cancer. , 2004, Lung cancer.

[16]  P. Boffetta Involuntary smoking and lung cancer. , 2002, Scandinavian journal of work, environment & health.

[17]  K. Sugimachi,et al.  Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  D. Christiani,et al.  The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  L. Kolonel,et al.  Intake of Flavonoids and Lung Cancer. , 2000, Journal of the National Cancer Institute.

[20]  N J Wald,et al.  The accumulated evidence on lung cancer and environmental tobacco smoke , 1997, BMJ.

[21]  G. Swanson,et al.  Familial risk of lung cancer among nonsmokers and their relatives. , 1996, American journal of epidemiology.

[22]  S. Barsky,et al.  Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features , 1994, Cancer.

[23]  L. Pickle,et al.  Epidemiology of bronchioloalveolar carcinoma. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  E. Wynder,et al.  Cigarette smoking and lung cancer cell types , 1991, Cancer.

[25]  S. Piantadosi,et al.  Recurrence and survival following resection of bronchioloalveolar carcinoma of the lung--The Lung Cancer Study Group experience. , 1989, Annals of surgery.

[26]  G. Friedman,et al.  Predictors of lung cancer: noteworthy cell type differences. , 2013, The Permanente journal.

[27]  L. Tanoue International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2012 .

[28]  B. Parodi,et al.  The CREST biorepository: a tool for molecular epidemiology and translational studies on malignant mesothelioma, lung cancer, and other respiratory tract diseases. , 2008, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  S. Land,et al.  GSTM 1 , GSTT 1 and GSTP 1 polymorphisms , environmental tobacco smoke exposure and risk of lung cancer among never smokers : a population-based study , 2005 .